Fresenius Medical (FMS) news
Recent news
Schaefer sees EUR 55M earnings effect in 2029
Schaefer, a German industrial company, has projected a EUR 55 million earnings impact by 2029, driven by strategic cost-cutting measures and operational efficiency improvements. This forecast aligns with broader industry trends, including rising interest rates and global economic uncertainty, which…
AInvest Wire · 2d agoTrading resumed: FMS (NYSE)
Trading resumed for Fresenius Medical Care AG (FMS) on the NYSE, with the stock trading at US$22.64 as of October 7, 2026, reflecting a 0.97% increase from the previous close . The company, which operates in the renal care sector through its Care Enablement and Care Delivery segments, has a market…
AInvest Wire · 7d agoFresenius Medical Care shares reverse, fall as much as 4.5%
Fresenius Medical Care (NYSE: FMS) shares experienced a notable decline on Monday, falling as much as 4.5% during early trading sessions. The drop followed the release of the company’s Q1 2026 investor presentation, which highlighted operational performance and market uncertainty . Investors…
AInvest Wire · 7d agoFresenius Medical Care shares spike 1.7% higher
Fresenius Medical Care (NYSE: FMS) shares rose 1.7% in early trading on October 7, 2026, following continued positive momentum from the broader Fresenius group. The company, a global leader in dialysis products and services, remains a key subsidiary of Fresenius SE & Co. KGaA, which has seen a…
AInvest Wire · 7d agoTrading halt: FMS (NYSE) - News pending
A trading halt has been imposed on FMS (NYSE) as the company awaits the release of pending news that could impact its stock price and investor sentiment. The halt, which is standard practice in such scenarios, aims to ensure market fairness and transparency by preventing trading until all relevant…
AInvest Wire · 7d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.